Dysregulated Bradykinin: Mystery in the Pathogenesis of COVID-19
Open Access
- 8 February 2022
- journal article
- review article
- Published by Wiley in Mediators of Inflammation
- Vol. 2022, 1-8
Abstract
The COVID-19 pandemic is rapidly spreading, and health care systems are being overwhelmed with the huge number of cases, with a good number of cases requiring intensive care. It has become imperative to develop safe and effective treatment strategies to improve survival. In this regard, understanding the pathogenesis of COVID-19 is highly important. Many hypotheses have been proposed, including the ACE/angiotensin-II/angiotensin receptor 1 pathway, the complement pathway, and the angiotensin-converting enzyme 2/mitochondrial assembly receptor (ACE2/MasR) pathway. SARS-CoV-2 binds to the ACE2 on the cell surface, downregulating the ACE2, and thus impairs the inactivation of bradykinin and des-Arg9-bradykinin. Bradykinin, a linear nonapeptide, is extensively distributed in plasma and different tissues. Kininogens in plasma and tissue are the main sources of the two vasoactive peptides called bradykinin and kallidin. However, the role of the dysregulated bradykinin pathway is less explored in the pathogenesis of COVID-19. Understanding the pathogenesis of COVID-19 is crucial for the development of new effective treatment approaches which interfere with these pathways. In this review, we have tried to explore the interaction between SARS-CoV-2, ACE2, bradykinin, and its metabolite des-Arg9-bradykinin in the pathogenesis of COVID-19.Keywords
This publication has 38 references indexed in Scilit:
- Bradykinin in asthma: Modulation of airway inflammation and remodellingEuropean Journal of Pharmacology, 2018
- Interaction of the Human Contact System with Pathogens—An UpdateFrontiers in Immunology, 2018
- Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltrationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2018
- Long‐term safety of icatibant treatment of patients with angioedema in real‐world clinical practiceAllergy, 2017
- Activation profiles of human kallikrein-related peptidases by matrix metalloproteinasesBiological Chemistry, 2012
- The kinin system--bradykinin: biological effects and clinical implications. Multiple role of the kinin system--bradykinin.2007
- Pathways for bradykinin formation and inflammatory diseaseJournal of Allergy and Clinical Immunology, 2002
- Angiotensin converting enzymes from human urine of mild hypertensive untreated patients resemble the N-terminal fragment of human angiotensin I-converting enzymeThe International Journal of Biochemistry & Cell Biology, 2001
- A Human Homolog of Angiotensin-converting EnzymeJournal of Biological Chemistry, 2000
- A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9Circulation Research, 2000